Patents by Inventor Hiroyuki Matsueda

Hiroyuki Matsueda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120065266
    Abstract: The present invention provides an oral composition which can more effectively prevent or improve functional gastrointestinal disorders, particularly upper gastrointestinal dysfunction, specifically functional dyspepsia, and is highly safe and suitable for long-term ingestion. The oral composition of the present invention contains sodium glutamate and arginine hydrochloride at a molar ratio of 1:1. The aforementioned composition can be provided as an agent for the prophylaxis or improvement of functional gastrointestinal disorder, and can also be provided in a food or drink.
    Type: Application
    Filed: September 13, 2011
    Publication date: March 15, 2012
    Applicants: NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY, AJINOMOTO CO. INC
    Inventors: Shinichi Fujita, Yoshiaki Hanzawa, Noriko Yasa, Hiroyuki Matsueda, Hideaki Kihara, Motoyasu Kusano, Osamu Kawamura, Yasuyuki Shimoyama, Hiroko Hosaka, Hiroaki Zai, Atsuto Nagoshi
  • Patent number: 7956041
    Abstract: The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.
    Type: Grant
    Filed: October 26, 2004
    Date of Patent: June 7, 2011
    Assignee: Ajinomoto Co., Inc.
    Inventors: Katsumi Maezono, Nozomu Ishida, Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Kageyama, Nobuo Kondo
  • Publication number: 20100063124
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: November 19, 2009
    Publication date: March 11, 2010
    Applicant: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Patent number: 7645787
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: January 12, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Patent number: 7632830
    Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: December 15, 2009
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Takao Ikenoue, Nobuo Kondo, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Masuzawa, Fumio Ohta, Akiyo Yamazaki, Seiji Niwa, Takashi Yamamoto
  • Publication number: 20080096862
    Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
    Type: Application
    Filed: November 30, 2007
    Publication date: April 24, 2008
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yukio IINO, Takao Ikenoue, Nobuo Kondo, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Masuzawa, Fumio Ohta, Akiyo Yamazaki, Seiji Niwa, Takashi Yamamoto
  • Patent number: 7326701
    Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: February 5, 2008
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Takao Ikenoue, Nobuo Kondo, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Masuzawa, Fumio Ohta, Akiyo Yamazaki, Seiji Niwa, Takashi Yamamoto
  • Publication number: 20070270479
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: July 6, 2007
    Publication date: November 22, 2007
    Applicant: AJINOMOTO CO. INC
    Inventors: Koji OHSUMI, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Patent number: 7256209
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: August 14, 2007
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Patent number: 7247616
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: July 24, 2007
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Patent number: 7247645
    Abstract: Compounds having a selective N-type calcium channel antagonistic activity are provided. Dihydropyridine derivatives represented by the following formula: analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel, and they are used as therapeutic agents for various diseases relating to N-type calcium channel.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: July 24, 2007
    Assignee: Ajinomoto Co., Inc.
    Inventors: Chika Nakanishi, Yoko Masuzawa, Masako Hagihara, Takashi Yamamoto, Hiroyuki Matsueda, Seiji Ohno, Seiji Niwa, Morikazu Kito, Akira Takahara, Yukitsugu Ono, Tomoko Takeda, Yuki Kajigaya, Hajime Koganei
  • Publication number: 20070099979
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: December 5, 2006
    Publication date: May 3, 2007
    Applicant: AJINOMOTO CO. INC
    Inventors: KOJI OHSUMI, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Patent number: 7153850
    Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: December 26, 2006
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Takao Ikenoue, Nobuo Kondo, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Masuzawa, Fumio Ohta, Akiyo Yamazaki, Seiji Niwa, Takashi Yamamoto
  • Publication number: 20060189597
    Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
    Type: Application
    Filed: April 6, 2006
    Publication date: August 24, 2006
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yukio Ilno, Takao Ikenoue, Nobuo Kondo, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Masuzawa, Fumio Ohta, Akiyo Yamazaki, Seiji Niwa, Takashi Yamamoto
  • Patent number: 7015201
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Grant
    Filed: September 9, 2004
    Date of Patent: March 21, 2006
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Publication number: 20060058244
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: October 24, 2005
    Publication date: March 16, 2006
    Applicant: AJINOMOTO CO. INC
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Patent number: 6930205
    Abstract: The present invention relates to a novel process for preparing an aminostilbene derivative, which is important as an active component of anticancer drugs or an intermediate for preparation thereof, as well as methods of producing the same.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: August 16, 2005
    Assignee: Ajinomoto Co., Inc.
    Inventors: Takashi Yamamoto, Hiroyuki Matsueda, Masaki Naito, Isao Arai, Masanobu Yatagai
  • Publication number: 20050143424
    Abstract: The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.
    Type: Application
    Filed: October 26, 2004
    Publication date: June 30, 2005
    Applicant: AJINOMOTO CO. INC
    Inventors: Katsumi Maezono, Nozomu Ishida, Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Kageyama, Nobuo Kondo
  • Patent number: 6908905
    Abstract: The present invention relates to pyrazole derivatives represented by the following formulas and analogues thereof, which can be used for a therapeutic agent for diabetes.
    Type: Grant
    Filed: October 27, 2003
    Date of Patent: June 21, 2005
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Nozomu Ishida, Yoko Kageyama, Katsumi Maezono, Nobuo Kondo
  • Publication number: 20050043249
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: September 9, 2004
    Publication date: February 24, 2005
    Applicant: AJINOMOTO CO. INC
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo